<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">299432</id>
  <title nil="true"/>
  <common-name>3-(2-fluorophenyl)-4-[(e)-(2-hydroxy-3,5-diiodophenyl)methylideneamino]-1h-1,2,4-triazole-5-thione</common-name>
  <description>3-(2-fluorophenyl)-4-[(e)-(2-hydroxy-3,5-diiodophenyl)methylideneamino]-1h-1,2,4-triazole-5-thione belongs to the triazoles, a subclass of azoles within the organic compounds. It is classified as an organoheterocyclic compound with the formula C15H9FI2N4OS. With an average molecular weight of 566.10 g/mol, 3-(2-fluorophenyl)-4-[(e)-(2-hydroxy-3,5-diiodophenyl)methylideneamino]-1h-1,2,4-triazole-5-thione is a heavy molecule.</description>
  <cas>579444-12-5</cas>
  <pubchem-id>135613196</pubchem-id>
  <chemical-formula>C15H9FI2N4OS</chemical-formula>
  <weight>566.1</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-28T15:59:15Z</created-at>
  <updated-at type="dateTime">2026-08-28T15:59:15Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C(=C1)C2=NNC(=S)N2N=CC3=C(C(=CC(=C3)I)I)O)F</moldb-smiles>
  <moldb-formula>C15H9FI2N4OS</moldb-formula>
  <moldb-inchi>InChI=1S/C15H9FI2N4OS/c16-11-4-2-1-3-10(11)14-20-21-15(24)22(14)19-7-8-5-9(17)6-12(18)13(8)23/h1-7,23H,(H,21,24)/b19-7+</moldb-inchi>
  <moldb-inchikey>CSSMSPGOBRNBLO-FBCYGCLPSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">565.85706</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM295325</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-(2-fluorophenyl)-4-[(e)-(2-hydroxy-3,5-diiodophenyl)methylideneamino]-1h-1,2,4-triazole-5-thione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0250744</sync-id>
  <structure-inchikey>CSSMSPGOBRNBLO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000804000000000000000800000000020020000000000000000002000000000800020800000200000000000000000100000000000000000000000800000000200000000000010000204000000021000000400000000000000000011000001000000008010000000000000010010004000008000000000008000000000000080000020000000000000000000010000000000000000000000000200000000000040000008000000000000000000000000000000000000000000000000000020202000000000000000000000000004a020000200000000000040000000008000000040000000000000800000000000000000080000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle>ï¾­Þ������������������������€��@h�������@h�������@h�������@(������@(������@h�������@(������@(������@8�������@(�������(������@(�������(�������h�������@(������@(������@(������@h�������@(������@h������5� ����5� ������h������	� �������h���h���h���h���h��� ��h���h��	h�	
(�	�h��� �(�� ��h���h���h���h���h��������� �����h���h���h�B���������������	������������������</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:09:46Z</structure-indexed-at>
</compound>
